Biology & biomedicine Technological offers
Treating Social Anxiety Disorders with Brain Hormones
- Details
- Category: Technological offers
-
18 Jun 2024
A team from the Institute of Neurosciences in Alicante (CSIC - UMH) has developed and patented a treatment for social disorders, such as anxiety or extreme introversion. It is based on the use of hormones that the brain naturally produces and which, as they have discovered, can regulate behavioral responses related to social interaction.
Lithium Nanocapsules for Cancer Treatment via Neutron Capture Therapy
- Details
- Category: Technological offers
-
10 Jun 2024
A team from the Institute of Materials Science of Barcelona (ICMAB) of the CSIC has developed carbon nanocapsules filled with enriched lithium compounds, which can be applied in Neutron Capture Therapy (NCT) for cancer treatment. They are now seeking industrial partners to continue the already patented development.
A biomaterial based on eggshell membrane for bone regeneration
- Details
- Category: Technological offers
-
30 Oct 2023
A multicentre study led by the CSIC has developed a biomaterial based on the eggshell membrane, which takes advantage of its natural qualities to obtain a biohybrid material with future applications in guided bone regeneration and pulp capping.
Obtaining three-dimensional cell cultures by ultrasound for in vitro studies
- Details
- Category: Technological offers
-
19 Feb 2024
A team from ITEFI CSIC has developed an ultrasound system that allows the generation of cellular clusters in the form of spheres for in vitro studies. It enables the straightforward creation of stable three-dimensional cell cultures in just a few minutes.
A new risk predictor for breast cancer that improves on commercial tests used in clinical practice
- Details
- Category: Technological offers
-
30 Jun 2023
The Laboratory of cancer bioinformatics and functional genomics from the Cancer Research Centre, a joint centre of the CSIC and the University of Salamanca (USAL), has designed a risk predictor for breast cancer patients using machine learning techniques. It allows the identification of genes associated with survival and risk of patients. The new test could be easily translated into the clinical practice, given that its development cost is similar to other routine techniques.
